Rentokil Initial (RTO) Stock Price, News & Analysis

Company Overview

Rentokil Initial plc is a United Kingdom-based business services company specializing in pest control, hygiene and workplace services. Through its pest control operations, the company provides inspection, prevention and treatment programs for residential, commercial and industrial customers, addressing insects, rodents, birds and other pests.

The company also supplies hygiene and washroom services, including sanitary products, restroom equipment, air-care systems and related maintenance programs. Its Ambius business provides interior and exterior landscaping services, such as office plants and living-wall installations, while other operations support workplace hygiene and related facility needs. Rentokil Initial serves customers across a broad range of industries, including food and beverage, healthcare, hospitality, retail, manufacturing and property management.

Rentokil Initial traces its roots to Rentokil, established in the United Kingdom in the first half of the 20th century, and the Initial hygiene business. The two companies combined in 1996 to form Rentokil Initial. The group has expanded internationally through organic growth and acquisitions, including its 2022 acquisition of Terminix, and serves customers across North America, Europe, Asia-Pacific, Africa and other international markets. Its American depositary shares trade on the New York Stock Exchange under the symbol RTO.

Key Stats

• Today's Range: $22.33 to $22.48
• 50-Day Range: $22.40 to $30.45
• 52-Week Range: $22.33 to $34.67
• Volume: 45,055 shs
• Average Volume: 1.29 million shs
• Market Capitalization: $11.29 billion
• P/E Ratio: N/A
• Dividend Yield: 1.61%
• Price Target: $31.90
• Consensus Rating: Moderate Buy

Rentokil Initial Stock Analysis - MarketRank™

Rentokil Initial scored higher than 74% of companies evaluated by MarketBeat, and ranked 248th out of 658 stocks in the industrials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Rentokil Initial has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, 7 buy ratings, 4 hold ratings, and 2 sell ratings.

Upside Potential

Rentokil Initial has a consensus price target of $31.90, representing about 42.4% upside from its current price of $22.40.

Amount of Analyst Coverage

Rentokil Initial has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 10.38%

Earnings Growth

Earnings for Rentokil Initial are expected to grow by 10.38% in the coming year, from $1.06 to $1.17 per share.

Price to Earnings Growth Ratio

Rentokil Initial has a PEG Ratio of 2.17. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Rentokil Initial has a P/B Ratio of 2.06. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.51% of the float of Rentokil Initial has been sold short.

Short Interest Ratio / Days to Cover

Rentokil Initial has a short interest ratio ("days to cover") of 2.03, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Rentokil Initial has recently decreased by 0.39%, indicating that investor sentiment is improving.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Rentokil Initial pays a meaningful dividend of 1.57%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Rentokil Initial does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Rentokil Initial will have a dividend payout ratio of 30.77% next year. This indicates that Rentokil Initial will be able to sustain or increase its dividend.

News and Social Media

• Score: 0.9 / 5
• News Sentiment: -0.49

News Sentiment

Rentokil Initial has a news sentiment score of -0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.75 average news sentiment score of Industrials companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Rentokil Initial this week, compared to 1 article on an average week.

Search Interest

Only 1 people have searched for RTO on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Rentokil Initial to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Rentokil Initial insiders have not sold or bought any company stock.

Percentage Held by Institutions

9.91% of the stock of Rentokil Initial is held by institutions.

Company Calendar

• Last Earnings: 8/06/2020
• Record date for 9/22 Dividend: 8/14/2026
• Ex-Dividend for 9/22 Dividend: 8/14/2026
• Today: 9/11/2026
• Dividend Payable: 9/22/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Industrials
• Industry: Commercial Services & Supplies
• Sub-Industry: Environmental & Facilities Services
• Current Symbol: NYSE:RTO
• CIK: 930157
• Web: www.rentokil-initial.com
• Phone: 441293858000
• Fax: N/A
• Employees: 63,388
• Year Founded: 1925

Price Target and Rating

• Average Price Target for Rentokil Initial: $31.90
• High Price Target: $35.00
• Low Price Target: $26.70
• Potential Upside/Downside: +42.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 14 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 21.13
• P/E Growth: 2.17
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.76
• Current Ratio: 1.16
• Quick Ratio: 1.07

Sales & Book Value

• Annual Sales: $6.91 billion
• Price / Sales: 1.64
• Cash Flow: $2.30 per share
• Price / Cash Flow: 9.75
• Book Value: $10.88 per share
• Price / Book: 2.06

Miscellaneous

• Outstanding Shares: 505,210,000
• Free Float: N/A
• Market Cap: $11.31 billion
• Optionable: Not Optionable
• Beta: 0.97